01 How it works
Everything GLOW does — collagen support from GHK-Cu, repair support from BPC-157 and TB-500 — plus KPV, which calms inflammation from inside cells.
02 Common uses
03 Run profile
A gentle first week, then a steady daily amount. Five days on, two off, best in the morning, in twelve-week blocks.
The profile shows the shape. Ask for the numbers for your vial, your goal and your timeline.
04 Pairs well with
05 What to watch for
Mostly injection-site irritation from the GHK-Cu. Same cautions as GLOW: not for copper disorders, and check with a doctor if you have a history of cancer.
06 Evidence & status
Not approvedNo trials on the blend; the evidence is that of its components.
Not FDA-approved.
Sources
- The Regenerative Potential of GHK-Cu in Aesthetic MedicineAesthetic Surgery Journal, 2026 · Review
- Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic ReviewHSS Journal, 2025 · Review
- Thymosin β4: a multi-functional regenerative peptide. Basic properties and clinical applicationsExpert Opinion on Biological Therapy, 2012 · Review
- PepT1-mediated tripeptide KPV uptake reduces intestinal inflammationGastroenterology, 2008 · Reference
- HHS Draft Policy Eases Enforcement on 6 Compounded PeptidesThe American Journal of Managed Care (AJMC), 2026 · Regulator document
- The Prohibited ListWorld Anti-Doping Agency, 2026 · Regulator document
- HHS Draft Policy Eases Enforcement on 6 Compounded PeptidesThe American Journal of Managed Care (AJMC), 2026 · Regulator document
Status and sources last checked November 3, 2026. Something out of date? Tell us.
07 How long until it works
No trial exists on the blend. The timescale is GHK-Cu’s for skin (about twelve weeks in the topical studies), with KPV’s anti-inflammatory effect expected sooner on the basis of animal work, within a couple of weeks. People report calmer skin first and texture later. The twelve-week block with a break is common use.
08 KLOW vs GLOW
The only difference is KPV. GLOW is GHK-Cu, BPC-157 and TB-500: collagen plus repair. KLOW adds KPV, the anti-inflammatory fragment of alpha-MSH, for skin that is inflamed, reactive or flaring, and for people who want gut-and-skin support in one vial. If the skin is not inflamed, GLOW is the simpler choice; if it is, KLOW is what people pick. Neither blend has been studied, and the KPV component has no human trials of its own.
The GLOW Stack dossier →09 Stacking
It is already a stack of four, and the usual advice is not to add to it. No study has tested the blend. Combined vials are outside the October 2026 HHS compounding policy.
10 Where it stands legally
None of the four components is approved as an injectable. KPV, BPC-157 and TB-500 are covered as single ingredients by the October 2026 HHS policy (KPV only as a topical or oral product); GHK-Cu’s status is unsettled; the blend is outside the policy.
In sport the blend is banned: TB-500 is named on WADA’s Prohibited List under S2, and the other components fall under S0.
11 FAQ
What is in it?
GHK-Cu 50mg, BPC-157 10mg, TB-500 10mg and KPV 10mg — 80mg in total.
When pick KLOW over GLOW?
When inflammation — reactive skin or gut issues — is part of the picture.
Does KPV change the sting?
No, the sting comes from the GHK-Cu.
Is the KLOW Stack banned in sport?
Yes. It contains TB-500, named under S2, plus unapproved peptides under S0.
Can a pharmacy compound the KLOW Stack?
No. The October 2026 HHS policy covers single-ingredient products only, and injected KPV and GHK-Cu are not covered even on their own.
Does the KPV change the sting?
Not noticeably; the sting is the GHK-Cu. More dilution and rotating sites are the fixes.
Educational information only — not medical advice. The Daily Stack does not sell or supply any products. Talk to a licensed healthcare professional about your own health decisions.